A Medscape Live Event at the 37th Annual EAU Congress SUNDAY, 3 JULY 2022 | 17:45 - 19:15 CET
Expert Guidance in Non-Muscle Invasive Bladder Cancer: Applying the Latest Recommendations to Clinical Practice
What is BC Care?
Instillation therapies for bladder cancer (BC) have a long tradition for our company. With BCG-medac and Mitomycin we offer the complete first-line arsenal for adjuvant treatment of non-muscle invasive bladder tumours of all risk classes. We have developed the first closed instillation system equipped as standard with all our designated bladder cancer drugs. Our service and competence is highly appreciated by urologists from all over the world.
BC CARE by medac stands for all this. We care about giving bladder cancer patients the optimal therapies. We care about personal safety of nurses, urologists and pharmacists.
We care about healthcare.
We care about Bladder Cancer
Despite being one of the most prevalent malignant diseases bladder cancer has a low public awareness. Informing patients and healthcare professionals alike is an important step in battling this disease.
We care about Healthcare Professionals
Personal safety of nurses, urologists and pharmacists is our particular concern. Therefore all our designated bladder cancer drugs are equipped with a closed instillation system.